{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Azaribine",
  "nciThesaurus": {
    "casRegistry": "2169-64-4",
    "chebiId": "",
    "chemicalFormula": "C14H17N3O9",
    "definition": "The triacetate salt of azauridine, a synthetic triazine nucleoside derivative possessing antineoplastic and anti-psoriatic activity. After metabolism to 6-azauridine-5-prime monophosphate, 6-Azauridine inhibits de novo pyrimidine biosynthesis and its 5-prime triphosphate metabolite gets incorporated into RNA, thereby preventing RNA synthesis.",
    "fdaUniiCode": "K1U80DO9EB",
    "identifier": "C1008",
    "preferredName": "Azaribine",
    "semanticType": "Nucleic Acid, Nucleoside, or Nucleotide",
    "subclassOf": [
      "C1557",
      "C2170"
    ],
    "synonyms": [
      "1,2,4-Triazine-3,5(2H,4H)-dione, 2-Beta-D-ribofuranosyl-",
      "2',3',4'-azauridine triacetate",
      "2-(2,3,5-Tri-O-acetyl-beta-D-ribofuranosyl)-as-triazine-3,5(2H,4H)-dione",
      "6-Azauridine Triacetate",
      "6-Azauridine triacetate",
      "AZARIBINE",
      "Azaribine",
      "Azauridine Triacetate",
      "Azauridine triacetate",
      "CB 304",
      "SKI 28426",
      "Triacetyl 6-azauridine",
      "Triacetyl 6-azuridine",
      "Triacetyl-6-azuridine",
      "Triazure"
    ]
  }
}